# Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma

> **NCT04577300** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Stanford University** · enrollment: 30 (estimated)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** NT-501
- **OTHER:** Sham comparator

## Key facts

- **NCT ID:** NCT04577300
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-05-15
- **Primary completion:** 2025-08-15
- **Final completion:** 2026-08-15
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04577300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04577300, "Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04577300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*